Persist AI (Series A)
Funding Details
Awarder
RSS - theaiinsider.tech
Date Award
May 23, 2025
Vertical
Pharmaceutical Development
Funding URL
View Funding Page
Funding Amount
$12,000,000
Company Info
Founding Year
2023
Traction
Persist AI serves multiple top 10 pharmaceutical clients and several smaller biotechs developing next-generation treatments for chronic diseases.
Organizations Involved
Eli Lilly & Company
Founders
Karthik Raman, Christopher Shelner
Market
Pharmaceutical Companies
Location
Sacramento, California, USA
Coinvestors
Spero Ventures, MBX Capital, Shimadzu Future Innovation Fund, Eli Lilly & Company, SignalFire, Ford Street Capital, Purdue Ventures, Good AI Capital, Cartography Capital, Asymmetry Ventures, 2048 Ventures, Innospark, YCombinator
Company Description

Persist AI is a biotechnology company that builds long-acting microsphere formulations.

Links
WebsiteCrunchbaseLinkedIn
Back to HomeBack to Pharmaceutical Development DealsView Funding Announcement